|
1
|
Center JR, Bliuc D, Nguyen TV and Eisman
JA: Risk of subsequent fracture after low-trauma fracture in men
and women. Jama. 297:387–394. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Iconaru L, Charles A, Baleanu F, Surquin
M, Benoit F, Mugisha A, Moreau M, Paesmans M, Karmali R, Rubinstein
M, et al: Prediction of an imminent fracture after an index
fracture-models derived from the frisbee cohort. J Bone Miner Res.
37:59–67. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Vasikaran S, Eastell R, Bruyère O, Foldes
AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S,
Trenti T, et al: Markers of bone turnover for the prediction of
fracture risk and monitoring of osteoporosis treatment: A need for
international reference standards. Osteoporos Int. 22:391–420.
2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tian A, Ma J, Feng K, Liu Z, Chen L, Jia H
and Ma X: Reference markers of bone turnover for prediction of
fracture: A meta-analysis. J Orthop Surg Res. 14(68)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zeng H, Li L, Zhang B, Xu X, Li G and Chen
M: Relationship between sleep pattern and bone mineral density in
patients with osteoporotic fracture. Ther Adv Endocrinol Metab.
13(20420188221106884)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wu CH, Chang YF, Chen CH, Lewiecki EM,
Wüster C, Reid I, Tsai KS, Matsumoto T, Mercado-Asis LB, Chan DC,
et al: Consensus statement on the use of bone turnover markers for
short-term monitoring of osteoporosis treatment in the asia-pacific
region. J Clin Densitom. 24:3–13. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Park SY, Ahn SH, Yoo JI, Chung YJ, Jeon
YK, Yoon BH, Kim HY, Lee SH, Lee J and Hong S: Position statement
on the use of bone turnover markers for osteoporosis treatment. J
Bone Metab. 26:213–224. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang ZQ, Ho SC, Chen ZQ, Zhang CX and
Chen YM: Reference values of bone mineral density and prevalence of
osteoporosis in Chinese adults. Osteoporos Int. 25:497–507.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Newson RB: Comparing the predictive powers
of survival models using Harrell's C or Somers' D. Stata J.
10:339–358. 2020.
|
|
10
|
Devogelaer JP, Boutsen Y, Gruson D and
Manicourt D: Is there a place for bone turnover markers in the
assessment of osteoporosis and its treatment? Rheum Dis Clin North
Am. 37:365–386, v-vi. 2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Shetty S, Kapoor N, Bondu JD, Thomas N and
Paul TV: Bone turnover markers: Emerging tool in the management of
osteoporosis. Indian J Endocrinol Metab. 20:846–852.
2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Naylor KE, Jacques RM, Paggiosi M, Gossiel
F, Peel NF, McCloskey EV, Walsh JS and Eastell R: Response of bone
turnover markers to three oral bisphosphonate therapies in
postmenopausal osteoporosis: the TRIO study. Osteoporos Int.
27:21–31. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lorentzon M, Branco J, Brandi ML, Bruyère
O, Chapurlat R, Cooper C, Cortet B, Diez-Perez A, Ferrari S,
Gasparik A, et al: Algorithm for the use of biochemical markers of
bone turnover in the diagnosis, assessment and follow-up of
treatment for osteoporosis. Adv Ther. 36:2811–2824. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ivaska KK, Gerdhem P, Väänänen HK, Akesson
K and Obrant KJ: Bone turnover markers and prediction of fracture:
A prospective follow-up study of 1040 elderly women for a mean of 9
years. J Bone Miner Res. 25:393–403. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Crandall CJ, Vasan S, LaCroix A, LeBoff
MS, Cauley JA, Robbins JA, Jackson RD and Bauer DC: Bone turnover
markers are not associated with hip fracture risk: A case-control
study in the women's health initiative. J Bone Miner Res.
33:1199–1208. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yao S, Laurent CA, Roh JM, Lo J, Tang L,
Hahn T, Ambrosone CB, Kushi LH and Kwan ML: Serum bone markers and
risk of osteoporosis and fragility fractures in women who received
endocrine therapy for breast cancer: A prospective study. Breast
Cancer Res Treat. 180:187–195. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Qu XL, Zheng B, Chen TY, Cao ZR, Qu B and
Jiang T: Bone turnover markers and bone mineral density to predict
osteoporotic fractures in older women: A retrospective comparative
study. Orthop Surg. 12:116–123. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Dai Z, Wang R, Ang LW, Yuan JM and Koh WP:
Bone turnover biomarkers and risk of osteoporotic hip fracture in
an Asian population. Bone. 83:171–177. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bauer DC, Garnero P, Harrison SL, Cauley
JA, Eastell R, Ensrud KE and Orwoll E: Osteoporotic Fractures in
Men (MrOS) Research Group. Biochemical markers of bone turnover,
hip bone loss, and fracture in older men: The MrOS study. J Bone
Miner Res. 24:2032–2038. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vilaca T, Gossiel F and Eastell R: Bone
turnover markers: Use in fracture prediction. J Clin Densitom.
20:346–352. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Eastell R, Pigott T, Gossiel F, Naylor KE,
Walsh JS and Peel NFA: DIAGNOSIS OF ENDOCRINE DISEASE: Bone
turnover markers: Are they clinically useful? Eur J Endocrinol.
178:R19–R31. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Migliorini F, Giorgino R, Hildebrand F,
Spiezia F, Peretti GM, Alessandri-Bonetti M, Eschweiler J and
Maffulli N: Fragility fractures: Risk factors and management in the
elderly. Medicina (Kaunas). 57(1119)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Moser SC and van der Eerden BCJ:
Osteocalcin-A versatile bone-derived hormone. Front Endocrinol
(Lausanne). 9(794)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zoch ML, Clemens TL and Riddle RC: New
insights into the biology of osteocalcin. Bone. 82:42–49.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wei J and Karsenty G: An overview of the
metabolic functions of osteocalcin. Curr Osteoporos Rep.
13:180–185. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kuo TR and Chen CH: Bone biomarker for the
clinical assessment of osteoporosis: Recent developments and future
perspectives. Biomark Res. 5(18)2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Manolagas SC: Osteocalcin promotes bone
mineralization but is not a hormone. PLoS Genet.
16(e1008714)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dumitru N, Carsote M, Cocolos A, Petrova
E, Olaru M, Dumitrache C and Ghemigian A: The link between bone
osteocalcin and energy metabolism in a group of postmenopausal
women. Curr Health Sci J. 45:47–51. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Razzaque MS: Osteocalcin: A pivotal
mediator or an innocent bystander in energy metabolism? Nephrol
Dial Transplant. 26:42–45. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Patti A, Gennari L, Merlotti D, Dotta F
and Nuti R: Endocrine actions of osteocalcin. Int J Endocrinol.
2013(846480)2013.PubMed/NCBI View Article : Google Scholar
|
